Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating alglucosidase alfa produced at the 4000 L manufacturing scale for Pompe disease. The study was terminated and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Myozyme (alglucosidase alfa)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pompe Disease | Phase 4 | Status: TERMINATED | Results posted: 2015-10-27